Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference


Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin's Chief Executive Officer, will participate in a fireside chat and panel at the H.C. Wainwright 26th Annual Global Investment Conference, taking place September 9-11, 2024 in New York, NY.

Mr. Drysdale's fireside chat will be webcast live on Monday, September 9, 2024, at 8:30 a.m. ET. To listen to the event, please click here to access the webcast. The archived webcast will also be available on the Company's investor relations website on the Events & Presentations page.

Mr. Drysdale will also participate in a panel discussion, titled "Psychedelics in Psychiatry: Breaking New Ground in Mood Disorders" at 3:00 p.m. ET on Tuesday, September 10, 2024.

About Cybin

Cybin is a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet need for people who suffer from mental health conditions.

With industry leading proof-of-concept data, Cybin is working to change the mental health treatment landscape through the introduction of intermittent treatments that provide long lasting results. The Company is currently developing CYB003, a proprietary deuterated psilocybin analog, about to enter Phase 3 studies for the adjunctive treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule in a Phase 2 study for generalized anxiety disorder. The Company also has a research pipeline of investigational, 5-HT-receptor focused compounds.

Founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.cybin.com or follow the team on X, LinkedIn, YouTube and Instagram.


These press releases may also interest you

at 03:35
Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) provided a positive opinion for the...

at 03:21
The International Olympic Committee (IOC), in collaboration with Alibaba.com, has officially launched the first phase of the fourth edition of the Athlete365 Business Accelerator programme, which aims to empower current and former elite athletes to...

at 03:19
During 25 November 2024 and 29 November 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 15,000 own B shares (ISIN: SE0016787071), corresponding to 0.004% of outstanding capital, as part of the share buyback...

at 03:00
SEMI, the industry association serving the global electronics design and manufacturing supply chain, today published recommendations for the European Union to bolster its semiconductor ecosystem. The SEMI Europe Recommendations for the 2024-2029...

at 03:00
Having millions of online purchases delivered home during the holiday season is often more sustainable than generally assumed. According to Hans Quak, Professor of Smart Cities and Logistics at Breda University of Applied Sciences (BUas), better...

at 03:00
Leading technology company Accesa, with 20 years of experience turning business challenges into opportunities for growth, and IT consulting and services company metafinanz, with its own successful-track record that spans over 30 years, are joining...



News published on and distributed by: